Delivery Order SPE2DB22D2007-SPE2DB24FJ0CP
- Not listed
- The Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order contract worth $1,437.75 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the provision of 4564085980 EPINEPHRINE 0.3 MG AUTO-INJECT 2S. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp, with a potential value of up to $999,999,999.00 through December 31, 2025. The IDC serves as the primary contract vehicle...
- The Defense Logistics Agency (DLA) awarded a $1,308.86 firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide EPINEPHRINE 0.3 MG AUTO-INJECT 2S. This order is part of a larger indefinite delivery contract (IDC) awarded by DLA to Amerisourcebergen Drug Corp, valued at up to $999,999,999.00 through December 31, 2025, to deliver pharmaceutical products and medical supplies to DLA Troop Support Medical facilities supporting the...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide EPINEPHRINE 0.3 MG AUTO-INJECT 2S. The contract has a potential value of $3,588.72 and a performance period through March 1, 2024. Amerisourcebergen Drug Corp, as the prime contractor, is also the holder of a larger indefinite delivery contract (IDC) with DLA valued up to $999,999,999.00 through...
- The Defense Logistics Agency (DLA) awarded a $3,368.13 firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide Epinephrine 0.3 mg auto-injectors. This delivery order is part of a larger indefinite delivery contract (IDC) valued at up to $999,999,999.00, which serves as the primary contract vehicle for Amerisourcebergen to deliver pharmaceutical products and medical supplies to DLA Troop Support Medical facilities supporting the...
- The Defense Logistics Agency (DLA) awarded a $5,616.71 delivery order contract to AmerisourceBergen Drug Corp's Corporate Office Division to provide EPINEPHRINE 0.3 MG AUTO-INJECT 2S. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 through December 31, 2025, which serves as the primary vehicle for AmerisourceBergen to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $4,512.40 to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide 4,564,147,555 units of epinephrine 0.3 mg auto-injectors. This delivery order is part of a larger indefinite delivery contract (IDC) with a potential value up to $999,999,999.00 that AmerisourceBergen Drug Corp holds with DLA to deliver a comprehensive range of pharmaceutical products and medical supplies...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide 4,563,971 units of 0.3 mg epinephrine auto-injectors. The $1,196.24 delivery order is part of a larger indefinite delivery contract (IDC) valued up to $999,999,999.00 that AmerisourceBergen Drug Corp holds with DLA to deliver pharmaceutical products and medical supplies to DLA Troop Support Medical facilities supporting the...
- The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract valued at $16,588.87 to Amerisourcebergen Drug Corp's Corporate Office Division for the supply of 4,564,359,634 units of epinephrine 0.3 mg auto-injectors. This order is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 that Amerisourcebergen holds with DLA Troop Support Medical, which serves as the primary vehicle for the company to deliver a comprehensive range of...
- The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract worth $2,128.60 to Amerisourcebergen Drug Corp's Corporate Office division for the supply of 4,564,339,573 units of epinephrine 0.3 mg auto-injector devices. This order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that Amerisourcebergen holds with DLA Troop Support Medical to provide a comprehensive range of pharmaceutical products and medical supplies to DLA facilities...
- The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract worth $2,143.03 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of 0.3 mg epinephrine auto-injectors. This order is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 2025. The IDC allows DLA to efficiently procure a wide range of pharmaceutical products and medical...
- SPE2DB22D2007Indefinite Delivery Contract
- SPE2DB22D2007-SPE2DB24FJ0CPDelivery Order
The Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order contract valued at $25,042.86 to Amerisourcebergen Drug Corp, the prime contractor, for the supply of EPINEPHRINE 0.3 MG AUTO-INJECT 2S. This award is part of Amerisourcebergen Drug Corp's broader indefinite delivery contract (IDC) with DLA, valued up to $999,999,999.00, which serves as the primary vehicle for the company to deliver pharmaceutical products and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense. The contract does not have a set-aside designation. Amerisourcebergen Drug Corp, a for-profit organization and subsidiary of Amerisourcebergen Corporation, has received numerous federal contract awards from DLA to supply pharmaceuticals, medical supplies, and related distribution services in support of military treatment programs and facilities.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $25.0k | 3/1/24 |